Iso-A11B5C1
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
LIPID 14 is a novel ionizable lipid used for mRNA delivery.In 2021, Elia et al. used lipid 2 LNPs and lipid 14 LNPs to deliver mRNA encoding SARSCoV-2 human Fc-conjugated receptor binding domain (RBDhFc mRNA). While both lipid 274 LNP RBD-hFc mRNA and lipid 14 LNP RBD-hFc mRNA induced equal cellular and humoral responses in mice at an mRNA dose of 5 μg, only lipid 14 LNP RBD-hFc mRNA exhibited strong immunogenicity following intradermal administration. Both intradermal administration and intramuscular administration of lipid 14 LNPs could activate antigen presenting cells (APCs), thus inducing cellular responses.
| CAS No. | 2430034-05-0 |
| Chemical Name | lipid 14 |
| Synonyms | lipid-14, lipid14 |
| SMILES | O=C(OCCN(CCCCCCCCOC(C(CCCCCC)CCCCCCCC)=O)CCCCCCCCOC(C(CCCCCC)CCCCCCCC)=O)CCCN(C)C |
| Formula | C56H110N2O6 |
| M.Wt | 907.48 |
| Purity | >95% by ELSD-HPLC |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Kon E, Levy Y, Elia U, et al. An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium. bioRxiv. 2022. Kon E, Levy Y, Elia U, et al. A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances. 2023;9(10):eadg1036. |
Lipid 14 is an ionizable lipid reported in preclinical mRNA vaccine research. The cited study evaluates formulated LNPs; its outcomes are specific to the tested formulation and animal model.
Complete component identity and a source-checked formulation record are required before a catalog mass calculation can be provided.
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
No N/P or lipid:RNA mass ratio was reported; no conversion is made.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 11.0195 mL | 2.2039 mL | 1.1020 mL |
| 25 mg | 27.5488 mL | 5.5098 mL | 2.7549 mL |
| 50 mg | 55.0976 mL | 11.0195 mL | 5.5098 mL |
| 100 mg | 110.1953 mL | 22.0391 mL | 11.0195 mL |
| 250 mg | 275.4882 mL | 55.0976 mL | 27.5488 mL |
Contact our team with the catalog number and requested quantity.